Answers are grounded in this paper and cite their sources.
Eight dimeric flavanes were isolated from the plant Psychotria calocarpa (Rubiaceae), including four stereoisomeric flavan-flavan-3-ol dimers (1-4) and four stereoisomeric flavan-3-ol-flavan-3-ol dimers (5-8). Among them, compounds 1-3 are newly identified flavan-(4→8)-flavan-3-ol dimers, named psychodiflavanols A-C, respectively. Their structures were elucidated by a comprehensive spectroscopic analysis combined with the quantum chemical calculations of electronic circular dichroism spectra. Compounds 4-8 were determined to be known flavan- (4→8)-flavan-3-ol dimer or flavan-3-ol-(4→8)-flavan-3-ol dimers based on comparison with literature data. All isolates were evaluated for their inhibitory activities against acetylcholinesterase, butyrylcholinesterase (BChE), α-glucosidase, and α-amylase. The results demonstrated that psychodiflavanol A (1) had potent and selective inhibition of BChE, with a half-maximal inhibitory concentration (IC50) value of 11.47 ± 2.12 µM. In addition, psychodiflavanol B showed a notable α-glucosidase inhibitory effect with an IC50 value of 10.15 ± 1.17 µM. These findings suggest that the flavane dimers from P. calocarpa might possess promising potential as lead compounds for developing therapeutic agents that target neurodegenerative and metabolic disorders.
No takes yet. Share an insight, caveat, or question.
Luo et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: